Tradestie Institutional Equity Comparison Engine

AURA vs DSGN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DSGN Overall Edge

DSGN Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Design Therapeutics, Inc. Common Stock (DSGN) driven by superior Growth & Margin, Momentum & Technical while AURA counters with relative strength in Options & Structure. Fundamentally, AURA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus DSGN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, AURA sits in CONSOLIDATION (22nd %ile IV; Dealer Gamma Walls on Pro) against DSGN sits in BREAKDOWN (13th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
AURA N/M vs DSGN N/M Fwd P/E
Growth & Margin Winner DSGN
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner DSGN
1Y +30.4% vs +40.8% ยท 52W Pos 52% vs 30%
Options & Structure Winner AURA
CONSOLIDATION (22nd %ile IV) vs BREAKDOWN (13th %ile IV)
AURA NASDAQ
Aura Biosciences, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$7.21
+1.41% 1D
Market Cap $728.6M
1M Return +18.2%
1Y Return +30.38%
Forward P/E N/M
Unified AI Score
31.1 / 100 SELL
Tech 8.0 Fund 39.0 Flow 71.0 Mom 44.0
DSGN NASDAQ
Design Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$9.94
-5.06% 1D
Market Cap $677.5M
1M Return -3.59%
1Y Return +40.79%
Forward P/E N/M
Unified AI Score
49.9 / 100 HOLD
Tech 55.0 Fund 56.0 Flow 63.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AURA +30.38% DSGN +40.79% Spread: +10.41 pp (DSGN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AURA TTM Op. Margin: 0.0% DSGN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AURA vs DSGN. Trailing 12-month operating profitability (AURA 0.0% vs DSGN 0.0%) and valuation multiples (AURA N/M vs DSGN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AURA (2) vs DSGN (3)
Institutional Metric AURA DSGN Criterion Row Winner
Market Capitalization Scale $728.6M $677.5M Larger Scale AURA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -61.7% -36.9% Higher ROE DSGN
52-Week Range Position Momentum 52% ($5โ€“$10) 30% ($7โ€“$17) Stronger Trend AURA
Beta / 30D Volatility Risk Regime 0.92ฮฒ ยท 75% Vol 1.32ฮฒ ยท 61% Vol Lower Realized Risk DSGN
Unified Institutional Score Composite Signal 31.1 / 100 (SELL) 49.9 / 100 (HOLD) Higher Composite DSGN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AURA vs DSGN Buy Guide
AURA CONSOLIDATION
135d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 22nd %ile
IV Regime Compressed (<25th %ile)
Live AURA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DSGN BREAKDOWN
139d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live DSGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AURA nor DSGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.